imeglimin: Clinical Trials

2 trials of imeglimin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Not yet recruiting 1

Follow imeglimin: new trials by email Literature Review of imeglimin trials Research Report on imeglimin

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy
Imeglimin, Metformin 1000 mg Oral Tablet - Mitochondria, Metformin
Phase 4Not yet recruitingMansoura University1762026-03-012026-02-27
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
Imeglimin, Metformin, Vildagliptin - Diabetes Mellitus, Type 2
Phase 4Active not recruitingNational Center for Global Health and Medicine, Japan5672022-05-262026-04-09

Conditions studied

Diabetes Mellitus, Type 2 (2)

Sponsors

Mansoura University (1)  ·  National Center for Global Health and Medicine, Japan (1)

Countries

Egypt (1)  ·  Japan (1)

Top investigators

Kohjiro Ueki, M.D., Ph.D. (1)

Results publications

PMID 33269554, PMID 33855213